Novel modalities and enabling technologies to expand the druggable target space
Targeted or intracellular delivery
Artificial intelligence for target and drug discovery
Genomic Medicine platforms
Roche is at the forefront when it comes to collaboration with biotechs at all development stages to drive the application of technology and modality platforms that have the potential to transform discovery as well as generate innovative medicines beyond the standard of care.
If you have an opportunity for collaboration or an interesting technology, or if you have an asset in one of our areas of interest, we would like to hear from you.